GlassScriptPhysician profile
Subbiah Rajaguru
NPI 1366450678
$8,151.77
in general payments reported to CMS, 2019-2025
24 companies · $376 in 2025
The $376 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,023 · 2020: $469 · 2021: $1,872 · 2022: $1,625 · 2023: $1,975 · 2024: $812 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,931 · Education: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,930.66 |
| Education | $232.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,048.86 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $836.07 | 2021-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $821.00 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $744.70 | 2019-2022 | |
| Biotronik INC. | $602.27 | 2020-2022 | |
| Biosense Webster, INC. | $505.79 | 2019-2023 | Qdot Micro Catheter, Carto 3, Octaray Mapping Catheter |
| Novo Nordisk INC | $427.66 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $383.52 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $364.10 | 2021-2025 | Farxiga, Brilinta |
| Impulse Dynamics (USA) INC. | $329.86 | 2021-2023 | Optimizer |
| Kowa Pharmaceuticals America, INC. | $307.53 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $307.10 | 2021-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $289.82 | 2022-2025 | Lifevest |
| Medtronic, INC. | $258.98 | 2021-2023 | Corevalve Evolut R |
| Abbott Laboratories | $214.96 | 2023-2025 | Jot Dx, Gallant |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $194.84 | 2023-2024 | Watchman Access System |
| Amgen INC. | $156.02 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.21 | 2022 | |
| Sanofi-Aventis U.S. LLC | $87.85 | 2022 | |
| Esperion Therapeutics, INC. | $57.59 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $36.15 | 2023 | Arcalyst |
| Irhythm Technologies, INC. | $29.59 | 2023 | Zio Xt Patch |
| Itamar Medical INC | $21.54 | 2023 | Watchpatone |
| Lexicon Pharmaceuticals, INC. | $13.76 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subbiah Rajaguru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.